Clinico-Biological Characteristics and Treatment Outcomes for Agressive Mantle Cell Lymphoma Patients Included in Clinical Trials. A Lysa Study

Hematological Oncology - United Kingdom
doi 10.1002/hon.48_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Outcomes for Patients With Mantle Cell Lymphoma Experiencing Frontline Treatment Failure: A Multicenter Retrospective Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Outcomes in First Relapsed-Refractory Younger Patients With Mantle Cell Lymphoma: Results From the Mantle-First Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Stem Cell Transplantation for Mantle Cell Lymphoma: Should It Ever Be Used Outside Clinical Trials?

Bone Marrow Transplantation
TransplantationHematology
2001English

Clinical Characteristics and Treatment Outcomes of Pediatric Patients With Non-Hodgkin Lymphoma in East Asia

Cancer Research and Treatment
Cancer ResearchOncology
2020English

New Treatment Options in Mantle Cell Lymphoma

European Oncology and Haematology
OncologyHematology
2015English

Outcome and Treatment of Relapsing Early Pet Negative Patients Included in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Splenectomy in the Treatment of Mantle Cell Lymphoma

Hematology & blood transfusion: interdepartamental collection
2016English

Emerging Therapy for the Treatment of Mantle Cell Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2014English

Outcomes of Diffuse Large B-Cell Lymphoma Patients Relapsing After Autologous Stem Cell Transplantation: An Analysis of Patients Included in the CORAL Study

Bone Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy